Dr. Kathie Seley-Radtke is a Professor in the Department of Chemistry & Biochemistry at the University of Maryland, Baltimore County. Her medicinal chemistry research focuses on targeting coronaviruses, filoviruses, flaviviruses among other infectious diseases, using her novel “fleximer” nucleoside/tide scaffolds. The fleximers have shown potent, broad-spectrum activity across many families of viruses and due to their flexibility, can retain their potency when confronted with binding site point mutations. Because of their potential to treat numerous pathogens of pandemic concern, as well as their ability to overcome variants and resistance mechanisms, the fleximers are of high interest all of the projects in the UNC READDI AViDD consortium. Dr. Seley-Radtke is currently the President of the International Society for Antiviral Research (ISAR), as well as a past President and current Secretary for the International Society for Nucleosides, Nucleotides & Nucleic Acids (IS3NA), Editor in Chief of Annual Reports in Medicinal Chemistry, and Associate Editor of Science Advances/AAAS and Antiviral Chemistry & Chemotherapy.
